CBER’s terror within
Executive Summary
The Center for Biologics Evaluation & Research allocates roughly 25% of its personnel and resources to counterterrorism-related activities. The center's major initiatives for 2004 included a BioShield-related guidance under development, creation of product labeling for strategic stockpiles and information on product security for manufacturers...
You may also be interested in...
QUOTED. 5 August 2020. Eric Fanning.
AdvaMed’s VentConnect platform is expanding to support production of devices needed to treat COVID-19. Here’s what Eric Fanning, CEO of participating group the Aerospace Industries Association, said about the move.
Warp Speed Lives Up To Its Name: FDA Planning Late October Vaccine Advisory Committee
Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.
Ahead Of Ryoncil’s Advisory Committee, Citizen Petition Opposes Approval For Pediatric GVHD
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Need a specific report? 1000+ reports available
Buy Reports